A randomized controlled trial of povidone‐iodine application after skin closure for prevention of surgical site infection in emergency cesarean section
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.15817 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Chantakarn Thaisriwong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Phrapokklao Hospital, Chanthaburi, Thailand. Hauptthemen laut MEDLINE: Povidone-Iodine, Surgical Wound Infection, Cesarean Section, Anti-Infective Agents, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Faculty of Medicine, Chulalongkorn University.
Abstract (Originalsprache)
Objective
To determine the effectiveness of povidone‐iodine application after skin closure to prevent surgical site infection after an emergency cesarean section and to assess risk factors associated with surgical site infection.
Methods
A randomized controlled trial enrolled 352 pregnant women who required emergency cesarean delivery at King Chulalongkorn Memorial Hospital, from August 2018 to March 2019. Participants were randomly assigned to receive the povidone‐iodine application at the incision after skin closure ( n = 176) or without application ( n = 176). Thirty‐day surveillance of complications and adverse effects was performed. The primary outcome was the incidence of surgical site infection, which was compared between groups using the chi‐squared test. The adjusted odds ratios (ORs) of the factors associated with surgical site infection were determined by logistic regression analysis.
Results
There were no significant differences in the incidence of surgical site infection and adverse effects between the povidone‐iodine and control groups (9.5% vs 7.1%, P = 0.430). The significant factor associated with surgical site infection was a long interval (≥60 min) from the administration of prophylactic antibiotics to the incision (adjusted OR 4.06, 95% CI 1.49–11.03).
Conclusion
The application of povidone‐iodine after skin closure in an emergency cesarean section did not have the advantage of reducing the incidence of surgical site infection. Clinical Trial Registration This study was registered in TCTR registry on March 10, 2018 with trial identification number: TCTR20180310002 ( https://www.thaiclinicaltrials.org/show/TCTR20180310002 ). The first participant was recruited on August 2, 2018.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Phrapokklao Hospital, Chanthaburi, Thailand.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Surasith Chaithongwongwatthana
Förderung
- Faculty of Medicine, Chulalongkorn University
Zitieren
APA
Thaisriwong, C., & Chaithongwongwatthana, S. (2025). A randomized controlled trial of povidone‐iodine application after skin closure for prevention of surgical site infection in emergency cesarean section. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15817
Vancouver
Thaisriwong C, Chaithongwongwatthana S. A randomized controlled trial of povidone‐iodine application after skin closure for prevention of surgical site infection in emergency cesarean section. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.15817
BibTeX
@article{Thaisriwong2025,
author = {Thaisriwong, Chantakarn and Chaithongwongwatthana, Surasith},
title = {A randomized controlled trial of povidone‐iodine application after skin closure for prevention of surgical site infection in emergency cesarean section},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.15817}
}
EUVIMED